COVID 19 vaccine - Gamaleya National Research Center of Epidemiology and Microbiology
Alternative Names: COVID-2019 vaccine - Gamaleya National Research Center of Epidemiology and Microbiology; Gam COVID Vak; Gam-COVID-Vac; single-dose Sputnik Light vaccine; Sputnik M; Sputnik V; Sputnik V vaccine; Sputnik-Light V vaccineLatest Information Update: 28 Aug 2024
Price :
$50 *
At a glance
- Originator Gamaleya Research Institute of Epidemiology and Microbiology
- Developer AstraZeneca; Dr Reddys Laboratories; Gamaleya Research Institute of Epidemiology and Microbiology; Pure Health; R-Pharm; The Government of Serbia
- Class COVID-19 vaccines; Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered COVID 2019 infections
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for clinical-Phase-Unknown development in COVID-2019-infections(Combination therapy, In the elderly, Prevention, In adults) in United Arab Emirates (IM, Injection)
- 05 Oct 2023 Gamaleya Research Institute of Epidemiology and Microbiology plans phase III trial for COVID 2019 infections (Prevention, In children, In adolescents ) in October 2023 (IM) (NCT06068556)
- 05 Oct 2023 Gamaleya Research Institute of Epidemiology and Microbiology plans phase-III trial for COVID-2019 infection (prevention) in September 2023 (IM, Injection) (NCT06057025)